On November 10, 2025 (U.S. Eastern Time), Zai Lab (9688) granted share options to subscribe for 500 American depositary shares (ADSs) and awarded 72,100 restricted share units (RSUs) to a total of 79 employee participants under its 2024 Equity Incentive Plan.

The share options allow the holder to subscribe for 500 ADSs, each ADS representing 10 ordinary shares, at an exercise price of US$24.5 per ADS. These options carry a ten-year validity period from the grant date, with 25% vesting on each anniversary for four years.

The 72,100 RSUs also vest in four equal annual installments of 25% each, subject to continuous employment. The closing price of the ADSs on the grant date was US$21.89 per ADS as quoted on NASDAQ, and the grants involve no performance targets or clawback mechanisms.

Following these grants, 79,839,923 shares remain available for future issuance under the 2024 Equity Incentive Plan. According to the announcement, these awards aim to acknowledge and reward contributions by employees and further incentivize their commitment to the company’s long-term objectives.